University of Oxford pauses pediatric trial of its vaccine with AstraZeneca, pending review by UK regulator

  • 📰 CNN
  • ⏱ Reading Time:
  • 20 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 95%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

A pediatric trial of the Oxford-AstraZeneca vaccine has been paused pending a review by the UK's medicines regulator of rare blood clot cases in adults, a University of Oxford spokesperson told CNN

The spokesperson said the trial in children had not raised any safety concerns, but it would be paused while Britain's Medicines and Healthcare products Regulatory Agency, or MHRA, reviews rare cases of people who suffer blood clots while at the same time having low levels of blood platelets."Parents and children should continue to attend all scheduled visits and can contact the trial sites if they have any questions," the spokesperson said.

They did not say how many blood clots might otherwise have been expected among 15.8 million peopleThe agency has advised the UK to continue administering the vaccine in all groups, arguing that such clotting incidents are very rare and that the benefits still greatly outweigh the risks, echoing similar assessments by the European Medicines Agency and the World Health Organization .

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

They are all free from prosecution and so no need to worry. Moderna hadn't passed animal trials in 10 years of working on medicine and now they are going into millions with no trials of matter. Crazy times

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in LAW

Law Law Latest News, Law Law Headlines